Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
07 Maggio 2024 - 10:01PM
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that
management will participate in a fireside chat at the Bank of
America Securities 2024 Healthcare Conference on Tuesday, May 14,
2024 at 10:40 a.m. Pacific Time (1:40 p.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible
through the Investors & Media section of the company’s website
at www.kiniksa.com. A replay of the event will also be available on
Kiniksa’s website within approximately 48 hours after the
event.
About KiniksaKiniksa is a commercial-stage
biopharmaceutical company focused on discovering, acquiring,
developing, and commercializing therapeutic medicines for patients
suffering from debilitating diseases with significant unmet medical
need. Kiniksa’s immune-modulating assets, ARCALYST®, abiprubart,
and mavrilimumab, are based on strong biologic rationale or
validated mechanisms, target a spectrum of underserved
cardiovascular and autoimmune conditions, and offer the potential
for differentiation. For more information, please
visit www.kiniksa.com.
ARCALYST® is a registered trademark of Regeneron
Pharmaceuticals, Inc.
Every Second
Counts! ®Kiniksa Investor and
Media ContactRachel Frank(339)
970-9437rfrank@kiniksa.com |
|
Grafico Azioni Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Storico
Da Giu 2023 a Giu 2024